Stocks
AstraZeneca PLC (AZN) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 442.5% | 442.5% | 379.7% | 379.7% | 289.4% | 274.1% | |||
| Changes by years, y/y, % | +213pp | 0pp | -63pp | 0pp | -90pp | -7.7% | |||
AstraZeneca PLC. R&D/CAPEX, %
AstraZeneca PLC. R&D/CAPEX, changes, pp
AstraZeneca PLC (AZN) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| R&D/CAPEX, % | 552.2% | 294.0% | 324.8% | 168.2% | 430.5% | 274.1% | ||
| Changes by years, y/y, % | +83pp | +82pp | -149pp | -9pp | -122pp | |||
| Changes by quarters, q/q, % | +375pp | -258pp | +31pp | -157pp | +262pp | |||
